安心交易
不成功退款,无后顾之忧,风险服务升级。PPAR Research is a peer-reviewed, Open Access journal that publishes original research and review articles on advances in basic research focusing on mechanisms involved in the activation of peroxisome proliferator-activated receptors (PPARs), as well as their role in the regulation of cellular differentiation, development, energy homeostasis and metabolic function. The journal also welcomes preclinical and clinical trials of drugs that can modulate PPAR activity, with a view to treating chronic diseases and disorders such as dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, and obesity.PPAR Research is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. For more information on Article Processing charges in general, click here.PPAR Research is included in many leading abstracting and indexing databases. For a complete list, click here.PPAR Research was founded in 2005 by Professor Mostafa Zaki Badr who served as the Editor-in-Chief of the journal between 2005 and 2011.The most recent Impact Factor for PPAR Research is 2.811 according to the 2016 Journal Citation Reports released by Clarivate Analytics in 2017.
PPAR研究是一份同行评审的开放获取期刊,发表有关基础研究进展的原创研究和评论文章,重点关注过氧化物酶体增殖激活受体(PPAR)的激活机制,以及它们在细胞分化、发育、能量稳态和代谢功能调控中的作用。该杂志还欢迎能够调节PPAR活性的药物的临床前和临床试验,以期治疗慢性疾病和疾病,如血脂异常、糖尿病、脂肪细胞分化、炎症、癌症、肺病、神经退行性疾病和肥胖。PPAR的研究被归档在Portico,它为电子学术期刊提供了永久的归档,也通过LOCKSS计划。它运行一个完全开放的访问发布模型,允许对其发布的内容进行开放的全局访问。这个模型是通过文章处理费来支持的。有关一般文章处理费的更多信息,请点击这里。PPAR研究包括在许多领先的抽象和索引数据库中。点击这里查看完整列表。PPAR研究由穆斯塔法·扎基·巴德教授于2005年创立,他曾在2005年至2011年间担任该杂志的主编。根据Clarivate Analytics在2017年发布的2016年期刊引文报告,PPAR研究的最新影响因素是2.811。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 3区 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 3区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q2 | MEDICINE, RESEARCH & EXPERIMENTAL | Q2 | 4.385 |
安心交易
不成功退款,无后顾之忧,风险服务升级。合规备案认证机构
资质许可齐全,合规经营,用户权益有保障。正刊保障
刊物在国家新闻出版署网可查,抵制假刊、增刊。对公账户资金监管
交易均通过对公账户,资金安全有保障。国内期刊
中文文章服务首选国际期刊
英文文章服务首选国际会议
会议文章服务首选评职加分
评职称文章服务首选812751拥有老客户
918539评职称指导
63352国际出版服务
819867开具合同